Log In
Print
BCIQ
Print
Print this Print this
 

Forfivo XL bupropion (CPI-300, INT0004)

  Manage Alerts
Collapse Summary General Information
Company IntelGenx Corp.
DescriptionOral antidepressant containing a high strength formulation of bupropion developed using IntelGenx's controlled-release drug delivery technology
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentMarketed
IndicationDepression
Partner

Edgemont Pharmaceuticals LLC
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today